摘要
目的:探讨生化检验项目在肝硬化疾病诊断中的临床价值。方法:选取2013年2月—2015年2月我院收治的31例肝硬化患者归为观察组,同期选取30例健康体检者作为对照组,采用AU400型自动生化分析仪检测两组主要生化检验项目并对比检测结果。结果:两组在丙氨酸转氨酶、总胆红素、谷草转氨酶、碱性磷酸酶、直接胆红素、胆碱酯酶、白蛋白八项主要生化检验项目检测结果上存在显著差异,且观察组检测结果明显偏离正常范围,P<0.05,有统计学意义。结论:肝硬化患者的主要生化检验项目与健康人群存在较大差异,可作为肝硬化的临床诊断指标。
Objective：To explore the clinical value of biochemistry tests in the diagnoses of cirrhosis. Methods：31 patients with cirrhosis admitted and treated in our hospital from February 2013 to February 2015 were included in the observation group while 30 cases of health examiniation were included in the control group, AU400 automatic biochemistry analyzer was used for the major biochemistry tests of two groups and the tests results were compared. Results：There was significant difference in the biochemistry tests of alanine aminotransferase, total bilirubin, glutamic-oxalacetic transaminase, alkaline phosphatase, direct bilirubin, cholinesterase and albumin of two groups, the results of the observation group were significantly abnormal, the difference was statistically significant（P〈0.05）. Conclusion：There was significant difference in the biochemistry tests results of patients with cirrhosis and healthy people, therefore, biochemistry tests results could be used as diagnostic index in the clinical diagnosis of cirrhosis.
出处
《中医临床研究》
2016年第3期24-25,共2页
Clinical Journal Of Chinese Medicine
关键词
生化检验
肝硬化
诊断
中医辨证
应用价值
Biochemistry tests
Cirrhosis
Diagnoses
TCM differentiation
Value
